Table 3 Univariable and multivariable analysis, predictors of mortality at long-term follow up.
From: Prognostic role of neoplastic markers in Takotsubo syndrome
Univariable | Multivariable | |||||||
|---|---|---|---|---|---|---|---|---|
Hazard ratio | Lower | Upper 95% CI | p | Hazard ratio | Lower | Upper 95% CI | p | |
Age | 1.15 | 1.08 | 1.22 | < 0.001 | 1.15 | 1.05 | 1.25 | 0.0025 |
Male gender | 1.43 | 0.42 | 4.85 | 0.5647 | ||||
Hypertension | 0.60 | 0.25 | 1.47 | 0.2675 | ||||
Dyslipidemia | 0.75 | 0.33 | 1.71 | 0.4941 | ||||
Obesity | 0.98 | 0.38 | 2.52 | 0.9704 | ||||
Smoke habit | 0.39 | 0.09 | 1.66 | 0.2001 | ||||
Diabetes | 1.59 | 0.62 | 4.08 | 0.3331 | ||||
COPD | 1.72 | 0.75 | 3.97 | 0.1997 | ||||
CKD | 1.57 | 0.64 | 3.82 | 0.3218 | ||||
History of cancer | 1.09 | 0.32 | 3.69 | 0.8936 | ||||
Admission Troponin I (ng/mL) | 1.04 | 0.99 | 1.09 | 0.1510 | ||||
Admission CRP (mg/L) | 1.01 | 1.00 | 1.01 | 0.0118 | 1.00 | 0.99 | 1.00 | 0.2367 |
Admission NTproBNP (pg/mL) | 1.00 | 1.00 | 1.00 | < 0.001 | 1.00 | 1.00 | 1.00 | 0.0271 |
Admission LVEF | 0.00 | 0.00 | 0.83 | 0.0432 | 0.01 | 0.00 | 34.91 | 0.2878 |
Reversible Mitral insufficiency | 1.34 | 0.72 | 2.50 | 0.3539 | ||||
RV involvement | 3.68 | 1.23 | 11.00 | 0.0197 | 1.87 | 0.57 | 6.11 | 0.3021 |
Negative T waves | 0.69 | 0.30 | 1.59 | 0.3865 | ||||
ST elevation | 1.13 | 0.50 | 2.57 | 0.7637 | ||||
ST depression | 0.03 | 0.00 | > 100 | 0.7148 | ||||
Number of markers (CEA, CA-19.9) with levels above median | 6.15 | 2.91 | 13.01 | < 0.001 | 3.92 | 1.68 | 9.16 | 0.0016 |
